Rebecca Harding
Overview
Explore the profile of Rebecca Harding including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
68
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Starr M, Harding R, Ataide R, Von Dinklage N, Sinharoy S, Jayasinghe Y, et al.
Lancet Glob Health
. 2025 Jan;
13(2):e285-e297.
PMID: 39890229
Background: Menstrual-related absenteeism from work, school, or social activities is an important functional indicator of poor menstrual health that disrupts women's and girls' daily lives and exacerbates gender inequality. We...
2.
Author Correction: Ferric carboxymaltose for anemia in late pregnancy: a randomized controlled trial
Pasricha S, Moya E, Ataide R, Mzembe G, Harding R, Mwangi M, et al.
Nat Med
. 2025 Jan;
31(1):351.
PMID: 39806073
No abstract available.
3.
Pasricha S, Moya E, Ataide R, Mzembe G, Harding R, Mwangi M, et al.
Nat Med
. 2025 Jan;
31(1):197-206.
PMID: 39762420
Over 46% of African pregnant women are anemic. Oral iron is recommended but often suboptimal, particularly late in pregnancy. Intravenous ferric carboxymaltose (FCM) could treat anemia in women in the...
4.
Mzembe G, Moya E, Mwangi M, Ataide R, Harding R, Kaunda J, et al.
Lancet Glob Health
. 2024 Nov;
12(12):e2049-e2058.
PMID: 39577976
Background: Anaemia is common in mothers and infants in the first year postpartum, especially in sub-Saharan Africa. We evaluated whether treating anaemia in the second trimester of pregnancy with a...
5.
Wall M, Harding R, Ertl N, Barba T, Zafar R, Sweeney M, et al.
Neurosci Insights
. 2024 Oct;
19:26331055241286518.
PMID: 39386147
Psychedelic therapies are an emerging class of treatments in psychiatry with great potential, however relatively little is known about their interactions with other commonly used psychiatric medications. As psychedelic therapies...
6.
Bennett C, Pettikiriarachchi A, McLean A, Harding R, Blewitt M, Seillet C, et al.
Am J Hematol
. 2024 Aug;
99(11):2075-2083.
PMID: 39152780
Serum iron has long been thought to exhibit diurnal variation and is subsequently considered an unreliable biomarker of systemic iron status. Circadian regulation (endogenous ~24-h periodic oscillation of a biologic...
7.
Harding R, Moya E, Ataide R, Truwah Z, Mzembe G, Mhango G, et al.
Gates Open Res
. 2024 Feb;
7:117.
PMID: 38343768
Background: Anemia affects 40% of pregnant women globally, leading to maternal mortality, premature birth, low birth weight, and poor baby development. Iron deficiency causes over 40% of anemia cases in...
8.
Pasricha S, Moya E, Ataide R, Mzembe G, Harding R, Phiri K
Lancet
. 2024 Jan;
403(10421):29-30.
PMID: 38184336
No abstract available.
9.
Mwangi M, Mzembe G, Ngwira C, Vokhiwa M, Kapulula M, Larson L, et al.
BMJ Open
. 2023 Oct;
13(10):e069011.
PMID: 37832986
Introduction: Approximately 40% of children aged 6-59 months worldwide are anaemic. Iron-containing multiple micronutrient powders (MNPs) and iron supplements (syrup/drops) are used to combat anaemia in children in different parts...
10.
Wall M, Harding R, Zafar R, Rabiner E, Nutt D, Erritzoe D
Mol Psychiatry
. 2023 Sep;
28(9):3573-3580.
PMID: 37759038
Psychedelic therapy (PT) is an emerging paradigm with great transdiagnostic potential for treating psychiatric disorders, including depression, addiction, post-traumatic stress disorder, and potentially others. 'Classic' serotonergic psychedelics, such as psilocybin...